Are you Dr. Lepore?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 52 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Civic Center Boulevard
East Pavilion, 2nd Floor
Philadelphia, PA 19104Phone+1 215-615-4949Fax+1 215-615-0829- Is this information wrong?
Summary
- Dr. John Lepore, MD is a cardiologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania.
Education & Training
- Massachusetts General HospitalFellowship, Cardiovascular Disease, 1996 - 1999
- Massachusetts General HospitalResidency, Internal Medicine, 1993 - 1996
- Harvard Medical SchoolClass of 1993
Certifications & Licensure
- PA State Medical License 2001 - 2021
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 4 citationsA Randomized, Placebo-Controlled Trial to Assess the Effects of 8 Weeks of Administration of GSK256073, a Selective GPR109A Agonist, on High-Density Lipoprotein Choles...Eric Olson, Kelly M. Mahar, Thomas F Haws, Michael J. Fossler, Feng Gao, Anne-Charlotte de Gouville, Dennis L. Sprecher, John J. Lepore> ;Clinical Pharmacology in Drug Development. 2019 Oct 1
- 79 citationsDaprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysisAmy M Meadowcroft, Borut Cizman, Louis Holdstock, Nandita Biswas, Brendan M Johnson, Delyth Jones, A Kaldun Nossuli, John J. Lepore, Michael Aarup, Alexander R. Cobitz> ;Clinical Kidney Journal. 2019 Feb 1
- 58 citationsDaprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney diseaseLouis Holdstock, Borut Cizman, Amy M Meadowcroft, Nandita Biswas, Brendan M Johnson, Delyth Jones, Sung Gyun Kim, Steven Zeig, John J. Lepore, Alexander R. Cobitz> ;Clinical Kidney Journal. 2019 Feb 1
- Join now to see all
Press Mentions
- Albiglutide Beats Placebo for Cardiovascular Events in T2DMOctober 4th, 2018
- Tanzeum Decreases Cardiovascular Events Among Diabetes PatientsOctober 2nd, 2018
Professional Memberships
- Member
- Member